Analysis and Evolution of Profitability in the Pharmaceutical Field in Romania
Abstract
The pharmaceutical industry is an important field of activity that contributes to the diagnosis, treatment, maintenance of the health of the population. The need of pharmaceuticals has led to an increase in both the number of drug manufacturers and the number of distributors. A significant part of the specialized studies deals with the problem of the profitability of the pharmaceutical industry. The study of the financial performance of the economic entities in the pharmaceutical field in Romania is a necessary concern in the conditions of a progressive annual increase of the profitability of this sector. The main purpose of this paper is the analysis and presentation of the evolution of profitability indicators (return on assets, return on capital, return on sales) as part of the activity of assessing the financial performance of economic entities operating in Romania in the pharmaceutical industry (manufacturing of basic pharmaceutical products - CAEN code 2110). Profitability indicators were analyzed for a number of 46 entities in the pharmaceutical industry in Romania for a period of 20 years (1999-2018). We are talking in this case about a turnover of 1.1 Billion lei (249.2 million euros), a number of employees of 3,098 employees, a profit of 135.2 million lei (30.7 million euros) - representing 0.12% of the net profit made in Romania. The research results show that in the period 2008-2009, the financial crisis left a strong mark on the evolution of profitability in the pharmaceutical industry. However, during the 20 years we talk about a positive evolution, in the sense of increasing the profitability of this field, which justifies the increase in the consumption of pharmaceuticals products.
References
Balteș N, Minculete (Piko) G. Current accounting reports - information source on assessing the financial performance of economic entities. Case study: pharmaceutical industry, CECCCAR Business Magazine, Business expertise and audit. 2017;2.
Beranova M, Polak J. Changes in view of financial position and performance of a company at application of IFRS in the Czech Republic. Acta academica karviniensia. 2014;14(1):16-23. Available from: https://aak.slu.cz/pdfs/aak/2014/01/02.pdf
Burja C. Economic-financial analysis: methodological aspects and practical applications. Cluj-Napoca: Casa Cărții de Știință Publishing House; 2009. pg. 290.
Burja V. The analysis of the financial statements of companies. Alba Iulia: Aeternitas Publishing; 2010.
Carp A, Mirea M. Profitability as a form of communication of the value of an entity that operates for profit. Romanian Statistical Review. 2017;6:184-191
Carp D. Romanian pharmaceutical market, record business in 2018, 2018 [Internet]. Available from: https://www.dcnews.ro/pia-a-farmaceutica-din-romania-afacerirecord-in-2018_586158.html
Căruntu C, Lăpăduși LM. Financial profitability rate. The impact of the rate of financial profitability on the development of the enterprise. Annals of Constantin Brâncuși University of Târgu Jiu, Economy Series. 2009;2:95-108.
Căruntu C, Lăpăduși LM. Measures to increase the rates of return based on the diagnosis analysis on factors. Annals of the Constantin Brâncuși University of Târgu Jiu, Economy Series. 2012;2:57-68.
CECCAR. Case Study on Entity Performance Assessment (II). Business Expertise and Audit. 2020;4. Available from: https://www.ceccarbusinessmagazine.ro/studiu-de-caz-privind-evaluarea-performantei-entitatilor-ii-a5896/
Deng Y, Zou S, You D. Financial performance evaluation of nuclear power-related enterprises from the perspective of sustainability, Environmental Science and Pollution Research. 2020;27(2):1-15. Available from: 10.1007/s11356-019-07545-1.
Fenyves V, Nyul B, Dajnoki K, Bacs Z, Tomori G. Profitability of Pharmaceutical Companies in the Visegrád Countries. Montenegrin Journal of Economics, Economic Laboratory for Transition Research (ELIT). 2019;15(4):99-111.
Ghic G, Grigorescu CJ. Economic-financial analysis: Individual study manual. Romania: Pro Universitaria Publishing House; 2012. pg. 65.
Hada ID. Considerations Regarding the Assessment and Measurement of Financial Performance. Lumen Proceedings. 2020;13. 16th International International Conference NCOE 4.0 2020:115 -129.
Issor Z. La performance de l’entreprise: un concept complexe aux multiples dimensions. Projectique. 2017;2(17):93-103.
Kolodziejka K. Pharmaceutical sector in the new reimbursement era. Management. 2012;16(1):203-215.
Leahy AS. The Determinants Of Profitability In The Pharmaceutical Industry. American Journal of Health Sciences. 2012;3(1):37-42
Mikulic M. Global Pharmaceutical Industry – Statistics & Facts [Internet]. 2019. Available from: https://www.statista.com/topics/1764/global-pharmaceutical-industry/
Nishanthini A, Nimalathasan B. Determinants of Profitability: A Case Study of Listed Manufacturing Companies in Sri Lanka. Journal of Management. 2013;VIII(1):42-50.
Paliu-Popa L, Cosneanu L. Profit and loss account in the international context. Annals of the Constantin Brâncuși University of Târgu Jiu, Economy Series. 2011;2:18-25.
Rotărescu AM. Biofarm financial performance analysis. ABC LUMII FINANCIARE working papers collection. 2017;5:211-230.
Stănică FA, Străchinaru AI, Ilie V. Influences on the profitability of the pharmaceutical industry in Romania. Theoretical and Applied Economics, Asociatia Generala a Economistilor din Romania – AGER. 2015;0(Special I):97-105.
Vasilescu L. Evaluation of the company's performance based on financial indicators. Annals of Constantin Brâncuși University of Târgu Jiu, Economics Series. 2011;3:159-166.
Vesa L. Financial Performance - Turning Point for the Economic Entity. ABC Financial World Working Paper Collection. 2018;7:182-191.
Top Firme [Internet]. Available from: www.topfirme.com
Ministerul Finanţelor Publice [Internet]. Available from: www.mfinante.ro
Copyright (c) 2020 LUMEN Proceedings
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Selection and peer-review under responsibility of the Organizing Committee of the conference.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
© LUMEN Proceedings Series 2022 . The LUMEN Proceedings Open Access volumes are distributed under the terms of the 